Aspen Neuroscience, which is developing stem cell therapies for Parkinson's disease, sold 9.37 million shares, slightly below ...

While praising the breadth of its pipeline, AstraZeneca has launched a three-year cost-cutting programme that will aim to ...

Belén Garijo, who took over the reins of the French pharma group in April, said this morning that Sanofi's "whole ...

A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis. Francisco Partners is ...

The US federal government has awarded $99 million in funding for a one-shot vaccine against the Bundibugyo virus (BDBV), the ...

Flagship Pioneering has formed a new AI-focused biotech company, called Etcelera, by combining the platforms of three firms ...

Dren Bio has closed a sizeable private financing round, raising $350 million to fund pivotal trials of its potentially ...

Eli Lilly has added another arrow to the quiver of its new diabetes and weight-loss therapy retatrutide, comprehensively ...

Among the highlights of UK Chancellor John Healey's first Budget was more than £1 billion in investment by Convatec, Vertex ...

Switzerland's Ferring Pharma has reached an agreement to buy US women's health startup Gameto for up to $1.38 billion, ...

A year after signing a first deal with Hansoh worth up to $1.45 billion, Roche has returned for another that could be more ...

While Anthropic has not disclosed the number of shares to be released, their price range, or a date for the listing, ...